|
Volumn 18, Issue 4, 2008, Pages 357-365
|
Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol
|
Author keywords
Induction; Membrane transport; Multidrug resistance related protein 2; Pharmacogenetics; Rifampicin; Talilonol
|
Indexed keywords
ABC TRANSPORTER;
ADENINE;
CYTOSINE;
GLYCOPROTEIN P;
GUANINE;
MESSENGER RNA;
PROTEIN ABCC2;
RIFAMPICIN;
TALINOLOL;
THYMINE;
UNCLASSIFIED DRUG;
ABCC2 GENE;
ADULT;
ALLELE;
ARTICLE;
CELL MEMBRANE TRANSPORT;
DRUG BIOAVAILABILITY;
DRUG CLEARANCE;
DUODENUM;
ENZYME INDUCTION;
FEMALE;
GENE;
GENE FREQUENCY;
GENETIC POLYMORPHISM;
GERMANY;
HAPLOTYPE;
HETEROZYGOTE;
HUMAN;
HUMAN EXPERIMENT;
INTESTINE;
MALE;
NORMAL HUMAN;
PHARMACOGENETICS;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SINGLE NUCLEOTIDE POLYMORPHISM;
UPREGULATION;
VOLUNTEER;
ADMINISTRATION, ORAL;
ADULT;
ANTIHYPERTENSIVE AGENTS;
BIOLOGICAL AVAILABILITY;
DNA PRIMERS;
DUODENUM;
FEMALE;
GENE FREQUENCY;
GENOTYPE;
HUMANS;
INFUSIONS, INTRAVENOUS;
INTESTINES;
MALE;
MEMBRANE TRANSPORT PROTEINS;
MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS;
NUCLEIC ACID SYNTHESIS INHIBITORS;
POLYMORPHISM, SINGLE NUCLEOTIDE;
PROPANOLAMINES;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
RIFAMPIN;
RNA, MESSENGER;
|
EID: 40549085349
PISSN: 17446872
EISSN: 17446880
Source Type: Journal
DOI: 10.1097/FPC.0b013e3282f974b7 Document Type: Article |
Times cited : (83)
|
References (49)
|